Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024

JAMA Surg. 2026 Jul 1;161(7):746-748. doi: 10.1001/jamasurg.2026.1343.

Authors

Robert J Calzaretta Jr¹, Stephen Fink¹, Kabir Kothari¹, Thomas C Tsai^{2

3

4}

Affiliations

¹ Analysis Group, Boston, Massachusetts and San Francisco, California.
² Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
³ Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
⁴ American College of Surgeons, Washington, DC.

PMID: 42126850
PMCID: PMC13173417 (available on 2027-05-13)
DOI: 10.1001/jamasurg.2026.1343

No abstract available

Plain language summary

This study examines trends in metabolic bariatric surgery utilization in the era of glucagon-like peptide-1 receptor agonists.